Get the Free Guide
The Research

How I decide what goes on this site.

Plenty of supplement sites cite research that doesn't actually support the claim it's attached to. Here's the standard I hold myself to, written down so you can check my work.

Every health claim maps to a named source.

Not "studies show." Not "research suggests." A specific paper, with its PubMed ID, listed at the bottom of the page so you can open it yourself and see whether it supports what I wrote. If a claim doesn't have a source I can point to, it doesn't go on the page — even when I believe it from clinical experience.

  1. Every citation is opened and read against PubMed directly — never pulled from another article's reference list or a summary.

  2. The full reference set is re-verified periodically, not just at the time of writing.

  3. No statistic appears on this site unless I can name the paper it came from.

Two Places Where This Costs Me Something

Standards are easy to write and hard to keep. These are the two clearest tests on this site.

I publish that digestive enzymes don't help GLP-1 bloating.

Enzymes are one of the easiest supplements to source and sell, and plenty of brands market them for exactly this. The evidence doesn't support it for GLP-1-related bloating, so I wrote an article saying so instead of adding an enzyme product.

I state plainly which magnesium has the trial evidence — and it isn't the one I sell.

Magnesium oxide has the randomized trial data for constipation. Citrate pulls harder, and in a 2003 head-to-head it also produced the highest serum levels. I sell bisglycinate, and I say all of that on the page rather than around it — then explain why it's still my daily choice: it absorbs well, it's far easier to tolerate day after day, and in a routine where fiber and triphala already handle bulk and motility, magnesium doesn't need to be the forceful one. You can read the full research review, including the parts that don't flatter my own product.

What I will not publish.

Claims that a supplement treats, cures, or prevents a disease. Before-and-after promises. Invented or rounded statistics. Citations I haven't personally opened. If a page can't be written honestly, I don't publish it.

  1. Structure and function language only, with the FDA disclaimer on every page.

  2. Educational content may name a medical condition; product claims may not.

  3. Health and product claims go through legal review before publishing.

Corrections

If you find a citation on this site that doesn't support the claim it's attached to, email hello@velisoma.com and I'll fix it. Corrections get made on the page, not quietly deleted. Pages carry a last-updated date so you can see when something changed.

I've already done this once: an article recommending a magnesium form was rewritten after I re-read the underlying evidence and found my own product page was arguing against itself. The science stayed; the recommendation changed to match it.

The Core Reference Set

Every entry below was pulled and checked against its PubMed record on 25 July 2026 — titles, journals, volumes and DOIs verified against the source, not copied from another page.

  1. Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus. Gorgojo-Martínez et al., J Clin Med 2022;12(1):145. PMID 36614945 · DOI.
  2. A randomized double-blind placebo-controlled trial on the effect of magnesium oxide in patients with chronic constipation. Mori et al., J Neurogastroenterol Motil 2019;25(4):563-575. PMID 31587548 · DOI.
  3. Randomised clinical trial: mixed soluble/insoluble fibre vs. psyllium for chronic constipation. Erdogan et al., Aliment Pharmacol Ther 2016;44(1):35-44. PMID 27125883 · DOI.
  4. Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies. Gunn et al., Gut 2021;71(5):919-927. PMID 34353864 · DOI.
  5. Triphala in gastrointestinal health: a review. Tarasiuk et al., Chin Med 2018. PMID 30034512.
  6. Evidence-based treatment recommendations for OTC management of chronic constipation. Rao & Brenner, J Am Assoc Nurse Pract 2022;34(9):1041-1044. PMID 35943487 · DOI.
  7. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Walker et al., Magnes Res 2003;16(3):183-91. PMID 14596323.
  8. Semaglutide half-life, duration in circulation, and constipation incidence: WEGOVY FDA prescribing information (sections 6.1 and 12.3).
These statements have not been evaluated by the Food and Drug Administration. Velisoma products are not intended to diagnose, treat, cure, or prevent any disease. This page describes editorial standards, not clinical outcomes.

Staying regular on a GLP-1: my simple daily routine.

Get my free guide — the three levers that work, and the mistakes I see people make.